_scan_pd.jpg)
In the financial interval ending December 31 2021 Bioventus Inc increased a shortfall per share at $-0.26 per share, opposite of $0.00 per share a year before reporting period, In the previous reporting period BVS realized $-0.02 per share.
from the previous reporting period from $-0.02 per share, from $81.78 millions.
In the fiscal fourth quarter of 2021 Bioventus Inc reported net shortfall of $-24.528 million, instead of balanced books in the corresponding reporting period a year ago.
Bioventus Inc is expected to report next financial results on March 10, 2023.